HKD 0.4
(-2.44%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 748.48 Million HKD | 2.85% |
2022 | 727.75 Million HKD | 9.24% |
2021 | 666.2 Million HKD | 7.95% |
2020 | 617.16 Million HKD | 10.44% |
2019 | 558.81 Million HKD | -1.51% |
2018 | 567.37 Million HKD | -3.12% |
2017 | 585.63 Million HKD | 13.93% |
2016 | 514.02 Million HKD | 12.72% |
2015 | 456.02 Million HKD | 13.71% |
2014 | 401.03 Million HKD | 12.82% |
2013 | 355.45 Million HKD | 11.46% |
2012 | 318.9 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q4 | 373.95 Million HKD | 0.0% |
2023 Q2 | 376.05 Million HKD | 0.0% |
2022 Q2 | 365.1 Million HKD | 0.0% |
2022 FY | 727.75 Million HKD | 9.24% |
2022 Q4 | 362.06 Million HKD | 0.0% |
2021 FY | 666.2 Million HKD | 7.95% |
2021 Q2 | 358.21 Million HKD | 0.0% |
2021 Q4 | 307.64 Million HKD | 0.0% |
2020 Q4 | 320.62 Million HKD | 0.0% |
2020 FY | 617.16 Million HKD | 10.44% |
2020 Q2 | 302.14 Million HKD | 0.0% |
2019 Q4 | 250.67 Million HKD | 0.0% |
2019 FY | 558.81 Million HKD | -1.51% |
2019 Q2 | 306.81 Million HKD | 0.0% |
2018 Q3 | 141.84 Million HKD | -45.91% |
2018 Q1 | 146.4 Million HKD | -40.66% |
2018 FY | 567.37 Million HKD | -3.12% |
2018 Q4 | 305.67 Million HKD | 115.5% |
2018 Q2 | 262.22 Million HKD | 79.11% |
2017 Q4 | 246.73 Million HKD | 68.52% |
2017 Q1 | 128.5 Million HKD | -51.66% |
2017 Q2 | 219.1 Million HKD | 70.5% |
2017 Q3 | 146.4 Million HKD | -33.18% |
2017 FY | 585.63 Million HKD | 13.93% |
2016 Q3 | 128.5 Million HKD | -48.71% |
2016 FY | 514.02 Million HKD | 12.72% |
2016 Q4 | 265.85 Million HKD | 106.88% |
2016 Q2 | 250.52 Million HKD | 119.75% |
2016 Q1 | 114 Million HKD | -52.55% |
2015 Q4 | 240.24 Million HKD | 110.73% |
2015 FY | 456.02 Million HKD | 13.71% |
2015 Q3 | 114 Million HKD | -47.72% |
2015 Q1 | 100.25 Million HKD | -51.34% |
2015 Q2 | 218.06 Million HKD | 117.51% |
2014 Q3 | 100.25 Million HKD | -49.17% |
2014 FY | 401.03 Million HKD | 12.82% |
2014 Q1 | 98.62 Million HKD | 0.0% |
2014 Q4 | 206.02 Million HKD | 105.49% |
2014 Q2 | 197.25 Million HKD | 100.0% |
2013 FY | 355.45 Million HKD | 11.46% |
2012 FY | 318.9 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 554.58 Million HKD | -34.965% |
Human Health Holdings Limited | 590.81 Million HKD | -26.687% |
EuroEyes International Eye Clinic Limited | 714.28 Million HKD | -4.788% |
Kato (Hong Kong) Holdings Limited | 271.33 Million HKD | -175.855% |
Bamboos Health Care Holdings Limited | 94.78 Million HKD | -689.654% |
Beijing Health (Holdings) Limited | 140.34 Million HKD | -433.317% |
C-MER Eye Care Holdings Limited | 1.92 Billion HKD | 61.097% |
Town Health International Medical Group Limited | 1.83 Billion HKD | 59.167% |
Medicskin Holdings Limited | 49.13 Million HKD | -1423.332% |
Hang Chi Holdings Limited | 211.21 Million HKD | -254.375% |